Clinicopathological staging of colorectal cancer: Evolution and consensus-an Australian perspective

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue SUPPL. 1, 2011, Pages 58-64

  Chapuis, Pierre H ^a   Chan, Charles ^a   Dent, Owen F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Clinicopathological staging; Colon cancer; Colorectal cancer; Rectal cancer

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; REVIEW;

EID: 78650794897     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06538.x     Document Type: Review

References (72)

1. Anderson WAD. Stage classification and end results reporting for carcinoma of the colon and rectum. Cancer 1974; 34: 909-11.
2. Cunningham D, Atkin A, Lenz H-J et al. Colorectal cancer. Lancet 2010; 375: 1030-47.
3. Van den Eynde M, Awada A, Hendlisz A. Is tailored adjuvant treatment for colon cancer possible? Clin. Colorectal Cancer 2010; 9: 15-21.
4. Fielding LP, Aresnault PA, Chapuis P et al. Working party report to the World Congresses of Gastroenterology, Sydney 1990. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J. Gastroenterol. Hepatol. 1991; 6: 325-44.
5. Dukes CE. The spread of cancer of the rectum. Br. J. Surg. 19291930; 17: 643-48.
6. Mainprize KS, Mortensen NJ, Warren BF. Dukes' staging is poorly understood by doctors managing colorectal cancer. Ann. R. Coll. Surg. Engl. 2002; 84: 23-5.
7. Chapuis PH, Newland RC, Dent OF. Staging in colon cancer. Semin. Colon Rectal Surg. 1991; 2: 9-16.
8. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 7th edn. New York: Springer, 2010.
9. National Health and Medical Research Council. Guidelines for the prevention, early detection and management of Colorectal Cancer (CRC). Canberra: National Health and Medical Research Council; 1999.
10. Bull AD, Biffin AHB, Mella J et al. Colorectal cancer pathology reporting: a regional audit. J. Clin. Pathol. 1977; 50: 138-42.
11. Keating J, Lolohea S, Kenwright D. Pathology reporting of rectal cancer: a national audit. N. Z. Med. J. 2003; 116: U415.
12. Wei JT, Miller EA, Woosley JT et al. Quality of colon carcinoma pathology reporting: a process of care study. Cancer 2004; 100: 1262-7.
13. Jestin P, Pahlman L, Glimelius B, Gunnarsson U. Cancer staging and survival in colorectal cancer. Ann. R. Coll. Surg. Engl. 2002; 84: 23-5.
14. Chapuis PH, Chan C, Lin BPC et al. Pathology reporting of resected colorectal cancers in New South Wales in 2000. ANZ J. Surg. 2007; 77: 963-9.
15. Jass JR. Future role of the pathologist in reporting colorectal cancer. World J. Surg. 1997; 21: 688-93.
16. Quirke P, Williams GT, Ectors N, Ensari A, Piard F, Nagtegaal I. The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol. 2007; 7: 651-57.
17. Branston LK, Greening S, Newcombe RG et al. the implementation of guidelines and computerised forms improve the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology. Eur. J. Cancer 2002; 38: 764-72.
18. Jass JR, O'Brien MJ, Riddell RH, Snover DC. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum. Pathol. 2007; 38: 537-45.
19. Royal College of Pathologists. Standards and Datasets for Reporting Cancers-Dataset for Colorectal Cancer, 2nd edn. London: RCP, 2007.
20. Royal College of Pathologists of Australasia. Colorectal Cancer Structured Reporting Protocol. Surry Hills. NSW: RCPA, 2010.
21. Thompson MR, Tekkis PP, Stamatakis J et al. The National Bowel Cancer Audit: the risks and benefits of moving to open reporting of clinical outcomes. Colorectal Dis. 2010; 12: 783-91.
22. Cross SS, Feeley KM, Angel CA. The effect of four interventions on the informational content of histopathology reports of resected colorectal carcinomas. J. Clin. Pathol. 1998; 51: 481-82.
23. Rigby K, Brown SR, Larkin G, Blasitis M, Hosie KB. The use of a proforma improves colorectal cancer pathology reporting. Ann. R. Coll. Surg. Engl. 1999; 81: 401-3.
24. Denoix PF. Importance of a classification common to the various forms of cancer. Acta Radiol. Suppl. 1954; 116: 122-9.
25. Denoix PF. Tumor, node and metastasis (TNM). Bull. Inst. Nat. Hyg. (Paris). 1954; 1: 1-69.
26. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 6th edn. New York: Springer, 2002.
27. Compton CC. Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch. Pathol. Lab. Med. 2006; 130: 318-24.
28. Shepherd NA, Baxter KJ, Love SB. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997; 112: 1096-102.
29. Newland RC, Dent OF, Lyttle MNB, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. Cancer 1994; 73: 2076-82.
30. Keshava A, Chapuis PH, Chan C, Lin BPC, Bokey EL, Dent OF. The significance of involvement of a free serosal surface for recurrence and survival following resectin of clinicopathological stage B and C rectal cancer. Colorectal Dis. 2007; 9: 609-18.
31. Darakhshan A, Lin BPC, Chan C, Chapuis PH, Dent OF, Bokey L. Correlates and outcomes of tumor adherence in resected colonic and rectal cancers. Ann. Surg. 2008; 247: 650-8.
32. Doekhie FS, Mesker WE, Kuppen PJ et al. Detailed examination of lymph nodes improves prognostication in colorectal cancer. Int. J. Cancer 2010; 126: 2644-52.
33. Moore J, Hyman N, Callas P, Littenberg B. Staging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survival. Surgery 2010; 147: 358-65.
34. McPartland S, Hyman N, Blaszyk H, Osler T. The number of lymph nodes in colon cancer specimens: what do the numbers really mean? Colorectal Dis. 2010; 12: 770-75.
35. Compton CC. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum. Excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the variform appendix: a basis for checklists. Cancer Committee. Arch. Pathol. Lab. Med. 2000; 124: 1016-25.
36. Washington MK, Berlin J, Branton P et al. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch. Path. Lab. Med. 2009; 133: 1539-51.
37. Hitchcock CL, Sampsel J, Young DC, Martin EW, Arnold MW. Limitations with light microscopy in the detection of colorectal cancer cells. Dis. Colon rectum 1999; 42: 1046-52.
38. Adam IJ, Mohamdee MO, Martin IG et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344: 707-11.
39. Davis NC, Newland RC. Terminology and classification of colorectal cancer: the Australian Clinicopathological Staging System. ANZ J. Surg. 1983; 53: 211-21.
40. Dent OF, Haboubi N, Chapuis PH et al. Assessing the evidence of an association between circumferential tumour clearance and local recurrence after resection of rectal cancer. Colorectal Dis. 2007; 9: 112-22.
41. Poston G. Improving the staging system in colorectal cancer. Clin. Adv. Hematol. Oncol. 2009; 7: 646-8.
42. Newland RC, Chapuis PH, Dent OF. Clinicopathological staging. In: Williams NS, ed. Colorectal Cancer. New York: Churchill Livingstone, 1996; 55-68.
43. Poston GJ, Figueras J, Giuliante F et al. Urgent need for a new staging system in advanced colorectal cancer. J. Clin. Oncol. 2008; 28: 4828-33.
44. Hamilton S, Vogelstein B, Kudo S et al. Tumours of the colon and rectum. In: Hamilton SR, Aaltonen LA, eds. World Health Organisation Classification of Tumours. Lyon: IARC Press, 2000; 101-42.
45. Compton CC. Colorectal carcinoma: diagnostic, prognostic, and molecularfeatures. Mod. Pathol. 2003; 16: 376-88.
46. Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet 1987; 1: 1303-6.
47. International Union Against Cancer. Prognostic Factors in Cancer, 1st edn. Berlin: Springer, 1995.
48. International Union Against Cancer. Prognostic Factors in Cancer, 3rd edn. Hoboken, New Jersey: Wiley, 2006.
49. Chapuis PH, Dent OF, Bokey EL, Newland RC, Sinclair G. Adverse histopathological findings as a guide to patient management after curative resection of node-positive colonic cancer. Br. J. Surg. 2004; 91: 349-54.
50. Sy J, Fung CL-S, Dent OF, Chapuis PH, Bokey L, Chan C. Tumor budding and survival after potentially curative resection of node-positive colon cancer. Dis. Colon Rectum 2010; 53: 301-7.
51. Markowitz SD, Bertagnolli M. Molecular basis of colorectal cancer. N. Engl. J. Med. 2009; 361: 2449-60.
52. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988; 319: 525-32.
53. Liu B, Nicolaides NC, Markowitz S et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat. Genet. 1995; 9: 48-55.
54. Jass JR, Do KA, Simms LA et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut 1998; 42: 673-9.
55. Gryfe R, Kim H, Hsieh ET et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N. Engl. J. Med. 2000; 342: 69-77.
56. Cawkwell L, Gray S, Murgatroyd H et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut 1999; 45: 409-15.
57. Ribic CM, Sargent DJ, Moore MJ et al. Tumor microsatellite-instability status as a predictor of benefitfrome fluorouracil-based adjuvant chemotherapy for colon cancer. N. Engl. J. Med. 2003; 349: 247-57.
58. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am. J. Clin. Pathol. 2005; 124: 380-91.
59. Umar A, Boland CR, Terdiman JP et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl. Cancer Inst. 2004; 18: 261-8.
60. Habermann JK, Bader FG, Franke C et al. From the genome to the proteome-biomarkers in colorectal cancer. Langenbecks Arch. Surg. 2008; 393: 93-104.
61. Karapetis CS, Khambata-Ford S, Jonker DJ et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N. Engl. J. Med. 2008; 359: 1757-65.
62. Daniels IR, Fisher SE, Heald RJ, Moran BJ. Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence. Colorectal Dis. 2007; 9: 290-301.
63. Skandarajah AR, Tjandra JJ. Preoperative loco-regional imaging in rectal cancer. ANZ J. Surg. 2006; 76: 497-504.
64. Muthusamy VR, Chang KJ. Optimal methods for staging rectal cancer. Clin. Cancer Res. 2007; 13 (Suppl. 22): s6877-84.
65. Yeung JM, Ferris NJ, Lynch AC, Heriot AG. Preoperative staging of rectal cancer. Future Oncol. 2009; 5: 1295-306.
66. Shin SS, Jeong YY, Min JJ, Kim HR, Chung TW, Kang HK. Preoperative staging of colorectal cancer: CT vs. integrated FDG PET/CT. Abdom. Imaging 2008; 33: 270-77.
67. Smith N, Brown G. Preoperative staging of rectal cancer. Acta Oncol. 2008; 47: 20-31.
68. Wolberink SVRC, Beets-Tan RGH, Nagtegaal ID, Wiggers T. Preoperative assessment of the circumferential margin in rectal cancer is more informative in treatment planning than the T stage. Tech. Coloproctol. 2006; 10: 171-6.
69. Purkayastha S, Tekkis PP, Athanasiou T, Tilney HS, Darzi AW, Heriot AG. Diagnostic precision of magnetic resonance imaging for preoperative prediction of the circumferential resection margin involvement in patients with rectal cancer. Colorectal Dis. 2007; 9: 402-11.
70. Dent OF, Chapuis PH, Haboubi N, Bokey L. Magnetic resonance imaging cannot predict histological tumour involvement of a circumferential surgical margin in rectal cancer. Colorectal Dis. 2010; DOI: (forthcoming).
71. Moran B, Brown G, Cunningham D et al. Clarifying the TNM staging of rectal cancer in the context of modern imaging and neo-adjuvant therapy treatment: "y", "u" and "p" need "mr" and "ct". Colorectal Dis. 2007; 10: 242-3.
72. Bateman AC, Jaynes E, Bateman AR. Rectal cancer staging post neoadjuvant therapy-how should the changes be assessed? Histopathology 2009; 54: 713-21.